See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Natural Disasters
Social Media
Republican Party
Tariffs
US Politics
Donald Trump
Trade War
Democratic Party
Vladimir Putin
Artificial Intelligence
European Union
Education
Published • loading... • Updated

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - Grace Therapeutics (NASDAQ:GRCE), Matinas BioPharma Hldgs (AMEX:MTNB)

Summary by Benzinga
BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE:MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward Neugeboren to its Board of Directors as independent members, effective March 11, 2025 (the "Effective Date"). In addition, Matthew Wikler, M.D., and Natasha Giordano stepped down from the Board on the Effective Date. "We are thrilled to announce the addition of Keit…

4 Articles

All
Left
Center
3
Right
Hastings TribuneHastings Tribune
Reposted by
Green Stock NewsGreen Stock News

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward Neugeboren to its Board of Directors as independent members, effective March 11, 2025…

Read Full Article
BenzingaBenzinga

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - Grace Therapeutics (NASDAQ:GRCE), Matinas BioPharma Hldgs (AMEX:MTNB)

BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE:MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward Neugeboren to its Board of Directors as independent members, effective March 11, 2025 (the "Effective Date"). In addition, Matthew Wikler, M.D., and Natasha Giordano stepped down from the Board on the Effective Date. "We are thrilled to announce the addition of Keit…

·New York, United States
Read Full Article
biopharmadive.combiopharmadive.com

SynWeave™: Revolutionizing biopharma manufacturing by improving titer, timelines and manufacturability

Enhancing manufacturability is crucial for reducing the risks associated with scaling production.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

biopharmadive.com broke the news in on Monday, March 10, 2025.
Sources are mostly out of (0)

Similar News Topics

American Express

American Express

United States

United States

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
Search
BlindspotLocal